Literature DB >> 24360326

Serum GGT activity and hsCRP level in patients with type 2 diabetes mellitus with good and poor glycemic control: An evidence linking oxidative stress, inflammation and glycemic control.

Mukesh G Gohel1, Anusha N Chacko2.   

Abstract

BACKGROUND: Diabetes is undoubtedly one of the most challenging health problems in 21st century. Understanding the pathogenesis and preventing long term complications have been major goals of research in diabetes mellitus (DM). Research in the past few years has linked oxidative stress and inflammation to beta cell dysfunction. Aim of this study is to evaluate serum gamma-glutamyl transferase (GGT) activity (marker of oxidative stress) and high sensitivity C reactive protein (hsCRP) level (an inflammatory marker) in type 2 DM subjects with good and poor glycemic control. Further, we investigated correlation between serum GGT and hsCRP level with glycemic control (FBS, PP2BS, HbA1c) in subjects.
METHODS: A cross sectional study consists of 150 patients out of them 50 patients having type 2 DM with good control (Group II), 50 patients with type 2 DM with poor control (Group III) and 50 normal healthy control (Group I) were selected. Serum GGT, serum hsCRP, FBS, PP2BS, HbA1c, and other biochemical investigations include serum liver enzymes and lipids were measured.
RESULTS: Mean serum GGT and hsCRP concentration were statistically significantly higher in group III patients compared to group I and group II subjects as well as increased in group II compared to group I (p < 0.001). Further significant positive correlation was observed between GGT and hsCRP concentration as well as both with HbA1c, FBS, and PP2BS.
CONCLUSIONS: Oxidative stress and inflammation appears to be a key component and also associated with poor glycemic control and further pathogenesis of diabetes and its complications. All our finding suggesting a link between oxidative stress, inflammation and glycemic control in patient with type 2 diabetes mellitus.

Entities:  

Year:  2013        PMID: 24360326      PMCID: PMC7962520          DOI: 10.1186/2251-6581-12-56

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  33 in total

Review 1.  Non-alcoholic fatty liver: a common manifestation of a metabolic disorder.

Authors:  S D H Malnick; M Beergabel; H Knobler
Journal:  QJM       Date:  2003-10

2.  Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity.

Authors:  Aldo Paolicchi; Michele Emdin; Erri Ghliozeni; Eugenio Ciancia; Claudio Passino; George Popoff; Alfonso Pompella
Journal:  Circulation       Date:  2004-03-23       Impact factor: 29.690

3.  Gamma-glutamyltransferase as a cardiovascular risk factor.

Authors:  Michele Emdin; Claudio Passino; Alfonso Pompella; Aldo Paolicchi
Journal:  Eur Heart J       Date:  2006-07-11       Impact factor: 29.983

4.  Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.

Authors:  Giovanni Targher; Lorenzo Bertolini; Felice Poli; Stefano Rodella; Luca Scala; Roberto Tessari; Luciano Zenari; Giancarlo Falezza
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

5.  Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.

Authors:  P André; B Balkau; C Born; M A Charles; E Eschwège
Journal:  Diabetologia       Date:  2006-09-13       Impact factor: 10.122

6.  gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women.

Authors:  Duk Hee Lee; Karri Silventoinen; David R Jacobs; Pekka Jousilahti; Jaakko Tuomileto
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

7.  The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals.

Authors:  G Targher; J C Seidell; M Tonoli; M Muggeo; G De Sandre; M Cigolini
Journal:  J Intern Med       Date:  1996-05       Impact factor: 8.989

Review 8.  Is serum gamma glutamyltransferase a marker of oxidative stress?

Authors:  Duk-Hee Lee; Rune Blomhoff; David R Jacobs
Journal:  Free Radic Res       Date:  2004-06

Review 9.  Inflammatory pathways and insulin action.

Authors:  G S Hotamisligil
Journal:  Int J Obes Relat Metab Disord       Date:  2003-12

10.  The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford
Journal:  Atherosclerosis       Date:  2003-06       Impact factor: 5.162

View more
  13 in total

1.  Safety of aerobic exercise in people with diabetic peripheral neuropathy: single-group clinical trial.

Authors:  Patricia M Kluding; Mamatha Pasnoor; Rupali Singh; Linda J D'Silva; Min Yoo; Sandra A Billinger; Joseph W LeMaster; Mazen M Dimachkie; Laura Herbelin; Douglas E Wright
Journal:  Phys Ther       Date:  2014-10-02

2.  Association of Serum hs-CRP Levels With the Presence of Obesity, Diabetes Mellitus, and Other Cardiovascular Risk Factors.

Authors:  Mahmoud Ebrahimi; Ali Reza Heidari-Bakavoli; Sara Shoeibi; Seyed Reza Mirhafez; Mohsen Moohebati; Habibollah Esmaily; Hamed Ghazavi; Maryam Saberi Karimian; Seyed Mohammad Reza Parizadeh; Maryam Mohammadi; Hossein Mohaddes Ardabili; Gordon A Ferns; Majid Ghayour-Mobarhan
Journal:  J Clin Lab Anal       Date:  2016-02-08       Impact factor: 2.352

3.  Association of serum kynurenine/tryptophan ratio with poor glycemic control in patients with type2 diabetes.

Authors:  Sara Abedi; Mahmood Vessal; Fatemeh Asadian; Mohammad Ali Takhshid
Journal:  J Diabetes Metab Disord       Date:  2021-09-12

4.  Is the Diabetes Epidemic Primarily Due to Toxins?

Authors:  Joseph Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2016-08

5.  Maternal circulating levels of some metabolic syndrome biomarkers in gestational diabetes mellitus.

Authors:  Ali Khosrowbeygi; Najmeh Shiamizadeh; Nima Taghizadeh
Journal:  Endocrine       Date:  2015-07-29       Impact factor: 3.633

6.  Investigating Molecular Connections of Non-alcoholic Fatty Liver Disease with Associated Pathological Conditions in West Virginia for Biomarker Analysis.

Authors:  Dana L Sharma; Hari Vishal Lakhani; Rebecca L Klug; Brian Snoad; Rawan El-Hamdani; Joseph I Shapiro; Komal Sodhi
Journal:  J Clin Cell Immunol       Date:  2017-09-29

Review 7.  The Application of Exercise Training for Diabetic Peripheral Neuropathy.

Authors:  Clifton J Holmes; Mary K Hastings
Journal:  J Clin Med       Date:  2021-10-28       Impact factor: 4.241

8.  The glucose-lowering effect of low-dose diacerein and its responsiveness metabolic markers in uncontrolled diabetes.

Authors:  Jintanan Jangsiripornpakorn; Sasima Srisuk; Laor Chailurkit; Hataikarn Nimitphong; Sunee Saetung; Boonsong Ongphiphadhanakul
Journal:  BMC Res Notes       Date:  2022-03-04

9.  The prevalence of diabetes amongst young Emirati female adults in the United Arab Emirates: A cross-sectional study.

Authors:  Maysm N Mohamad; Leila Cheikh Ismail; Lily Stojanovska; Vasso Apostolopoulos; Jack Feehan; Amjad H Jarrar; Ayesha S Al Dhaheri
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

10.  Serum Levels of Gamma-Glutamyltransferase During Stable and Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Authors:  Desheng Sun; Hongyan Liu; Yao Ouyang; Xiansheng Liu; Yongjian Xu
Journal:  Med Sci Monit       Date:  2020-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.